Literature DB >> 27263497

Determinants of resting cerebral blood flow in sickle cell disease.

Adam M Bush1, Matthew T Borzage2, Soyoung Choi3, Lena Václavů4, Benita Tamrazi5, Aart J Nederveen4, Thomas D Coates6, John C Wood5,7.   

Abstract

Stroke is common in children with sickle cell disease and results from an imbalance in oxygen supply and demand. Cerebral blood flow (CBF) is increased in patients with sickle cell disease to compensate for their anemia, but adequacy of their oxygen delivery has not been systematically demonstrated. This study examined the physiological determinants of CBF in 37 patients with sickle cell disease, 38 ethnicity matched control subjects and 16 patients with anemia of non-sickle origin. Cerebral blood flow was measured using phase contrast MRI of the carotid and vertebral arteries. CBF increased inversely to oxygen content (r(2)  = 0.69, P < 0.0001). Brain oxygen delivery, the product of CBF and oxygen content, was normal in all groups. Brain composition, specifically the relative amounts of grey and white matter, was the next strongest CBF predictor, presumably by influencing cerebral metabolic rate. Grey matter/white matter ratio and CBF declined monotonically until the age of 25 in all subjects, consistent with known maturational changes in brain composition. Further CBF reductions were observed with age in subjects older than 35 years of age, likely reflecting microvascular aging. On multivariate regression, CBF was independent of disease state, hemoglobin S, hemoglobin F, reticulocyte count and cell free hemoglobin, suggesting that it is regulated similarly in patients and control subjects. In conclusion, sickle cell disease patients had sufficient oxygen delivery at rest, but accomplish this only by marked increases in their resting CBF, potentially limiting their ability to further augment flow in response to stress. Am. J. Hematol. 91:912-917, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27263497      PMCID: PMC4987198          DOI: 10.1002/ajh.24441

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  41 in total

Review 1.  Cerebrovascular disease in African Americans.

Authors:  P B Gorelick
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

2.  Transfusions for silent cerebral infarcts in sickle cell anemia.

Authors:  Michael R DeBaun; James F Casella
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

3.  Cerebral blood flow changes in benign aging and cerebrovascular disease.

Authors:  T G Shaw; K F Mortel; J S Meyer; R L Rogers; J Hardenberg; M M Cutaia
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

4.  Developmental changes of cerebral blood flow and oxygen metabolism in children.

Authors:  T Takahashi; R Shirane; S Sato; T Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  1999-05       Impact factor: 3.825

5.  Arterial spin labeling measurement of cerebral perfusion in children with sickle cell disease.

Authors:  Sanna Gevers; Aart J Nederveen; Karin Fijnvandraat; Sandra M van den Berg; Pim van Ooij; Dennis F Heijtel; Harriët Heijboer; Paul J Nederkoorn; Marc Engelen; Matthias J van Osch; Charles B Majoie
Journal:  J Magn Reson Imaging       Date:  2011-11-16       Impact factor: 4.813

6.  Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell disease.

Authors:  Veronica van der Land; Henri J M M Mutsaerts; Marc Engelen; Harriët Heijboer; Mark Roest; Martine J Hollestelle; Taco W Kuijpers; Paul J Nederkoorn; Marjon H Cnossen; Charles B L M Majoie; Aart J Nederveen; Karin Fijnvandraat
Journal:  Br J Haematol       Date:  2015-10-22       Impact factor: 6.998

7.  Regional cerebral blood flow and oxygen consumption in human aging.

Authors:  P Pantano; J C Baron; P Lebrun-Grandié; N Duquesnoy; M G Bousser; D Comar
Journal:  Stroke       Date:  1984 Jul-Aug       Impact factor: 7.914

8.  Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease.

Authors:  Isak Prohovnik; Anne Hurlet-Jensen; Robert Adams; Darryl De Vivo; Steven G Pavlakis
Journal:  J Cereb Blood Flow Metab       Date:  2009-02-11       Impact factor: 6.200

9.  Predictors of cerebral blood flow in patients with and without anemia.

Authors:  Matthew T Borzage; Adam M Bush; Soyoung Choi; Aart J Nederveen; Lena Václavů; Thomas D Coates; John C Wood
Journal:  J Appl Physiol (1985)       Date:  2016-01-21

10.  Increased cerebral arterial pulsatility in patients with leukoaraiosis: arterial stiffness enhances transmission of aortic pulsatility.

Authors:  Alastair J S Webb; Michela Simoni; Sara Mazzucco; Wilhelm Kuker; Ursula Schulz; Peter M Rothwell
Journal:  Stroke       Date:  2012-08-23       Impact factor: 7.914

View more
  40 in total

1.  Differences in Activation and Deactivation in Children with Sickle Cell Disease Compared with Demographically Matched Controls.

Authors:  B Sun; R C Brown; T G Burns; D Murdaugh; S Palasis; R A Jones
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

Review 2.  Measuring success: utility of biomarkers in sickle cell disease clinical trials and care.

Authors:  Ram Kalpatthi; Enrico M Novelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  Quantification of whole-brain oxygenation extraction fraction and cerebral metabolic rate of oxygen consumption in adults with sickle cell anemia using individual T2 -based oxygenation calibrations.

Authors:  Wenbo Li; Xiang Xu; Peiying Liu; John J Strouse; James F Casella; Hanzhang Lu; Peter C M van Zijl; Qin Qin
Journal:  Magn Reson Med       Date:  2019-09-04       Impact factor: 4.668

4.  Reduced oxygen extraction efficiency in sickle cell anemia patients with evidence of cerebral capillary shunting.

Authors:  Meher R Juttukonda; Manus J Donahue; Spencer L Waddle; Larry T Davis; Chelsea A Lee; Niral J Patel; Sumit Pruthi; Adetola A Kassim; Lori C Jordan
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-11       Impact factor: 6.200

5.  Noninvasive optical assessment of resting-state cerebral blood flow in children with sickle cell disease.

Authors:  Seung Yup Lee; Kyle R Cowdrick; Bharat Sanders; Eashani Sathialingam; Courtney E McCracken; Wilbur A Lam; Clinton H Joiner; Erin M Buckley
Journal:  Neurophotonics       Date:  2019-08-19       Impact factor: 3.593

6.  Unwinding the path from anemia to stroke.

Authors:  John C Wood
Journal:  Blood       Date:  2018-03-01       Impact factor: 22.113

7.  Preliminary evidence for cerebral capillary shunting in adults with sickle cell anemia.

Authors:  Meher R Juttukonda; Manus J Donahue; Larry T Davis; Melissa C Gindville; Chelsea A Lee; Niral J Patel; Adetola A Kassim; Sumit Pruthi; Jeroen Hendrikse; Lori C Jordan
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-20       Impact factor: 6.200

8.  Red cell exchange transfusions lower cerebral blood flow and oxygen extraction fraction in pediatric sickle cell anemia.

Authors:  Kristin P Guilliams; Melanie E Fields; Dustin K Ragan; Cihat Eldeniz; Michael M Binkley; Yasheng Chen; Liam S Comiskey; Allan Doctor; Monica L Hulbert; Joshua S Shimony; Katie D Vo; Robert C McKinstry; Hongyu An; Jin-Moo Lee; Andria L Ford
Journal:  Blood       Date:  2017-12-18       Impact factor: 22.113

9.  Pseudo continuous arterial spin labeling quantification in anemic subjects with hyperemic cerebral blood flow.

Authors:  Adam Bush; Yaqiong Chai; So Young Choi; Lena Vaclavu; Scott Holland; Aart Nederveen; Thomas Coates; John Wood
Journal:  Magn Reson Imaging       Date:  2017-12-09       Impact factor: 2.546

10.  Profiling cerebrovascular function in migraine: A systematic review and meta-analysis.

Authors:  Jemima Sa Dzator; Peter Rc Howe; Rachel Hx Wong
Journal:  J Cereb Blood Flow Metab       Date:  2020-10-22       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.